DK0441605T3 - Thiazolidin-derivater med anti-diabetisk virkning samt deres fremstilling og anvendelse - Google Patents

Thiazolidin-derivater med anti-diabetisk virkning samt deres fremstilling og anvendelse

Info

Publication number
DK0441605T3
DK0441605T3 DK91300959.3T DK91300959T DK0441605T3 DK 0441605 T3 DK0441605 T3 DK 0441605T3 DK 91300959 T DK91300959 T DK 91300959T DK 0441605 T3 DK0441605 T3 DK 0441605T3
Authority
DK
Denmark
Prior art keywords
preparation
well
thiazolidine derivatives
hydrogen
diabetic action
Prior art date
Application number
DK91300959.3T
Other languages
English (en)
Inventor
Takao Yoshioka
Takashi Fujita
Tsutomu Kanai
Kanichi Nakamura
Hiroyoshi Hirikoshi
Kunihiro Sasahara
Takeshi Kinoshita
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of DK0441605T3 publication Critical patent/DK0441605T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
DK91300959.3T 1990-02-07 1991-02-06 Thiazolidin-derivater med anti-diabetisk virkning samt deres fremstilling og anvendelse DK0441605T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2802390 1990-02-07

Publications (1)

Publication Number Publication Date
DK0441605T3 true DK0441605T3 (da) 1996-07-29

Family

ID=12237153

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91300959.3T DK0441605T3 (da) 1990-02-07 1991-02-06 Thiazolidin-derivater med anti-diabetisk virkning samt deres fremstilling og anvendelse

Country Status (11)

Country Link
US (1) US5143930A (da)
EP (1) EP0441605B1 (da)
KR (1) KR0184601B1 (da)
AT (1) ATE136544T1 (da)
AU (1) AU637456B2 (da)
CA (1) CA2035832C (da)
DE (1) DE69118565T2 (da)
DK (1) DK0441605T3 (da)
ES (1) ES2088459T3 (da)
FI (1) FI910583A7 (da)
GR (1) GR3020196T3 (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE93138T1 (de) * 1990-02-09 1993-09-15 Upjohn Co Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie.
GB9124513D0 (en) * 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
NO302471B1 (no) * 1991-12-26 1998-03-09 Sankyo Co Tiazolidinforbindelser og farmasöytisk preparat
NO302519B1 (no) * 1991-12-26 1998-03-16 Sankyo Co Tiazolidinforbindelser som inneholder en kinongruppe, og farmasöytisk preparat
ATE185564T1 (de) * 1992-08-31 1999-10-15 Sankyo Co Oxazolidin-derivate mit antidiabetika und anti- fettleibigkeit-eigenschaften, ihre herstellung und therapeutische verwendung
FR2696743B1 (fr) * 1992-10-12 1994-12-23 Adir Nouveaux composés de thiazolidine dione, leur procédé de préparation et les compositions pharmaceutiques les contenant.
TW245716B (da) * 1992-12-28 1995-04-21 Takeda Pharm Industry Co
JP3195455B2 (ja) * 1993-01-06 2001-08-06 ウェルファイド株式会社 キノリン−3−酢酸誘導体、その製造法と用途
TW268952B (da) * 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd
NO305987B1 (no) * 1994-04-11 1999-08-30 Sankyo Co Heterosykliske forbindelser med antidiabetisk aktivitet, deres anvendelse og farmasoeytisk preparat inneholdende disse
CA2159938A1 (en) 1994-10-07 1996-04-08 Hiroaki Yanagisawa Oxime derivatives, their preparation and their therapeutic use
CZ293016B6 (cs) * 1995-06-01 2004-01-14 Sankyo Company Limited Benzimidazolové deriváty a farmaceutické prostředky s jejich obsahem
US5919782A (en) * 1996-05-06 1999-07-06 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
ZA973848B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them.
US5801173A (en) * 1996-05-06 1998-09-01 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
ZA973850B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel antidiabetic compounds having hypolipidaemic, anti-hypertensive properties, process for their preparation and pharmaceutical compositions containing them.
US6372750B2 (en) 1996-07-01 2002-04-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
US5885997A (en) * 1996-07-01 1999-03-23 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6114526A (en) * 1996-07-01 2000-09-05 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
USRE39266E1 (en) * 1996-07-01 2006-09-05 Dr. Reddy's Laboratories, Limited Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
AU744518B2 (en) 1996-07-01 2002-02-28 Dr. Reddy's Laboratories Limited Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
ATE267814T1 (de) 1997-10-08 2004-06-15 Sankyo Co Substituierte kondensierte heterocyclische verbindungen
US6946295B2 (en) * 1998-06-12 2005-09-20 Cellfor, Inc. Process for ex vitro sowing and germination of plant somatic embryos
US6028088A (en) * 1998-10-30 2000-02-22 The University Of Mississippi Flavonoid derivatives
TWI284533B (en) * 1999-05-24 2007-08-01 Sankyo Co Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant
WO2002050024A2 (en) * 2000-12-18 2002-06-27 Smithkline Beecham Corporation Thiazolidinediones
US8912335B2 (en) 2009-12-15 2014-12-16 Metabolic Solutions Development Company, Llc PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases
PL2560956T3 (pl) 2010-04-19 2017-03-31 Octeta Therapeutics, Llc Nowa synteza związków tiazolidynodionowych
KR101857307B1 (ko) 2010-08-10 2018-05-11 메타볼릭 솔루션스 디벨롭먼트 컴퍼니, 엘엘씨 티아졸리딘디온 화합물의 합성법
CA2807662C (en) 2010-08-10 2019-10-08 Metabolic Solutions Development Company, Llc Synthesis for thiazolidinedione compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4873255A (en) * 1987-02-04 1989-10-10 Sankyo Company Limited Thiazolidinone derivatives, their preparation and their use
FI904414A7 (fi) * 1988-03-08 1990-09-07 Pfizer Tiatsolidiinidioni-hypoglykeemisesti vaikuttavat aineet
US4933355A (en) * 1988-04-14 1990-06-12 Sankyo Company Limited Thiazole derivatives, their preparation and their use in the treatment of diabetes complications
GB8919434D0 (en) * 1989-08-25 1989-10-11 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
ES2088459T3 (es) 1996-08-16
ATE136544T1 (de) 1996-04-15
HK1005451A1 (en) 1999-01-08
AU637456B2 (en) 1993-05-27
CA2035832A1 (en) 1991-08-08
CA2035832C (en) 2000-08-29
KR910015552A (ko) 1991-09-30
DE69118565D1 (de) 1996-05-15
EP0441605B1 (en) 1996-04-10
AU7090691A (en) 1991-08-08
DE69118565T2 (de) 1997-01-09
EP0441605A2 (en) 1991-08-14
EP0441605A3 (en) 1992-01-22
GR3020196T3 (en) 1996-09-30
KR0184601B1 (ko) 1999-05-01
FI910583A0 (fi) 1991-02-07
FI910583A7 (fi) 1991-08-08
US5143930A (en) 1992-09-01

Similar Documents

Publication Publication Date Title
AU637456B2 (en) Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
DK0412404T3 (da) Thiazolderivater, fremgangsmåder til fremstilling deraf og farmaceutiske præparater omfattende derivaterne
ATE26120T1 (de) Substituierte acyl-derivate von 1,2,3,4tetrahydro-6,7-dimethoxy-3-isoquinolincarbons|ure.
FI906204A0 (fi) Menetelmä farmaseuttisesti vaikuttavien peptidiyhdisteiden valmistamiseksi
JPS6479184A (en) Pyrazolotriazine derivative
EP0541120A3 (en) Xanthine derivatives for the treatment of dementia
ES8704445A1 (es) Procedimiento de preparar derivados aminicos
SE8406141L (sv) N-acylaminosyradiamidderivat, salter derav, forfarande for deras framstellning och antiulcermedel innehallande dessa
PT83104A (en) Novel guanidinomethylbenzoic acid derivatives
MY141488A (en) Hydroximic acid derivatives, processes for their preparation, and compositions comprising them
ES510004A0 (es) "un procedimiento para preparar derivados de n-naftoilglicina".
FI881104A0 (fi) Menetelmä antidiabeettisina aineina käytettävien bentsoksatsiinijohdannaisten valmistamiseksi
ATE168691T1 (de) Makrolid-derivate
DE3579189D1 (de) Heterocyclische aminoverbindungen.
DK14691D0 (da) 4-substituerede anthracyclinoner og anthracyclinglycosider samt deres fremstilling
IT1197841B (it) Derivati pirido-benzotiazinici ad attivita' antibatterica ed a lunga durata di azione
ATE112682T1 (de) Isocarbacyclinderivate enthaltende antidiabetika.
ATE129246T1 (de) Pyrazolo(1,5-a)pyridine, deren herstellung und verwendung.
LU88449I2 (fr) Fleroxacine et ses dérivés pharmaceutiquement acceptables.